Geopolitics Alpha

8-K - Sonoma Pharmaceuticals, Inc. (0001367083) (Filer)

Published . Updated .

Filed: 2026-10-06 AccNo: 0001683168-26-007657 Size: 663 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits

Directly affected

  • SNOA Sonoma Pharmaceuticals

    Named in this report.

Indirectly affected

  • XPH STATE STREET SPDR S&P PHARMACEUTICALS ETF

    GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
SNOA———————
XPH———————

Filed: 2026-10-06 AccNo: 0001683168-26-007657 Size: 663 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws;…

Source: sec-edgar

The price since 7 Oct 2026: Sonoma Pharmaceuticals (SNOA) versus the S&P 500

Since the first closing price after “8-K - Sonoma Pharmaceuticals, Inc. (0001367083) (Filer),” Sonoma Pharmaceuticals (SNOA) is -2.56%. The S&P 500 fund (SPY) is -0.94% over the same days, a -1.62% difference versus the market.

SNOA
SPY

Who gains and who loses around Sonoma Pharmaceuticals (SNOA)

Companies tied to this story

  • SNOA Sonoma Pharmaceuticals

    Sonoma Pharmaceuticals (SNOA) is linked, with no stored direction, high confidence in the 7 Oct 2026 story “8-K - Sonoma Pharmaceuticals, Inc. (0001367083) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> SNOA

  • XPH State Street Spdr S&P Pharmaceuticals Etf

    State Street Spdr S&P Pharmaceuticals Etf (XPH) is linked, with no stored direction, medium confidence in the 7 Oct 2026 story “8-K - Sonoma Pharmaceuticals, Inc. (0001367083) (Filer).” Reason on file: GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article

How “8-K - Sonoma Pharmaceuticals, Inc. (0001367083) (Filer)” reaches Sonoma Pharmaceuticals (SNOA)

Sonoma Pharmaceuticals (SNOA) is the company in “8-K - Sonoma Pharmaceuticals, Inc. (0001367083) (Filer),” the 7 Oct 2026 this story story.

For Sonoma Pharmaceuticals (SNOA), the reason on file says SEC 8-K filing -> direct issuer disclosure -> SNOA

A second company, State Street Spdr S&P Pharmaceuticals Etf (XPH), is listed for a different reason: GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article

Dates in the story, and the Sonoma Pharmaceuticals (SNOA) price range

SNOA traded between 1.12 and 1.25 across 9 sessions. The latest close on file is 1.14. XPH traded between 61.54 and 68.95 across 20 sessions. The latest close on file is 62.24.

How strong the case is around Sonoma Pharmaceuticals (SNOA)

21 out of 100

“8-K - Sonoma Pharmaceuticals, Inc. (0001367083) (Filer)” scores 21 out of 100. The score uses 1 sources, and 2 linked companies.